Cipla Ltd.
BSE: 500087 | NSE: CIPLA
Large Cap | Pharmaceuticals & Drugs
1426.80
-11.95 (-0.83%) Cipla - Quaterly Results
Date: 12-05-2023
A minor change in the total revenue was seen in the March 2023 quarter. The total revenue for the quarter stood at Rs. 38937.40 millions against Rs. 37345.90 millions during year ago period.The Company to register a -44.39% fall in the net profit for the quarter ended March 2023.A decline of 9194.90 millions was observed in the OP in the quarter ended March 2023 from 9415.70 millions on QoQ basis.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202303 | 202203 | % Var | 202303 | 202203 | % Var | 202303 | 202203 | % Var | |
| Sales | 38937.40 | 37345.90 | 4.26 | 157906.00 | 153808.20 | 2.66 | 157906.00 | 153808.20 | 2.66 |
| Other Income | 1197.10 | 3163.10 | -62.15 | 4567.90 | 6667.00 | -31.48 | 4567.90 | 6667.00 | -31.48 |
| PBIDT | 9194.90 | 9415.70 | -2.35 | 42493.70 | 43779.30 | -2.94 | 42493.70 | 43779.30 | -2.94 |
| Interest | 104.60 | 57.80 | 80.97 | 270.20 | 269.30 | 0.33 | 270.20 | 269.30 | 0.33 |
| PBDT | 7231.30 | 9357.90 | -22.73 | 40364.50 | 43510.00 | -7.23 | 40364.50 | 43510.00 | -7.23 |
| Depreciation | 1615.80 | 1367.20 | 18.18 | 5959.10 | 5466.20 | 9.02 | 5959.10 | 5466.20 | 9.02 |
| PBT | 5615.50 | 7990.70 | -29.72 | 34405.40 | 38043.80 | -9.56 | 34405.40 | 38043.80 | -9.56 |
| TAX | 2060.60 | 1598.60 | 28.90 | 9710.10 | 9218.00 | 5.34 | 9710.10 | 9218.00 | 5.34 |
| Deferred Tax | -385.80 | -0.50 | 77060.00 | -400.90 | -276.90 | 44.78 | -400.90 | -276.90 | 44.78 |
| PAT | 3554.90 | 6392.10 | -44.39 | 24695.30 | 28825.80 | -14.33 | 24695.30 | 28825.80 | -14.33 |
| Equity | 1614.30 | 1613.60 | 0.04 | 1614.30 | 1613.60 | 0.04 | 1614.30 | 1613.60 | 0.04 |
| PBIDTM(%) | 23.61 | 25.21 | -6.34 | 26.91 | 28.46 | -5.46 | 26.91 | 28.46 | -5.46 |